News tagged with plavix
FDA warning: some patients cannot process Plavix
(AP) -- The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.
Medicine & Health / Medications
Mar 12, 2010 |
4.3 / 5 (3) |
1
Newer Anti-Clotting Medication Found to Be More Effective
(PhysOrg.com) -- A large head-to-head study of two anti-clotting medications for heart patients has found that the investigational compound ticagrelor (Brilinta) was more effective at reducing cardiovascular death than the ...
Medicine & Health / Medications
Aug 30, 2009 |
4 / 5 (2) |
0
Study shows experimental drug cuts stroke risk
(AP) -- An experimental drug reduces the stroke risk in patients with irregular heartbeats by more than three times, compared with the popular drug warfarin - but possibly at a cost, according to new research released Sunday.
Medicine & Health / Medications
Aug 30, 2009 |
5 / 5 (1) |
0
Study: Plavix plus aspirin helps prevent strokes
(AP) -- Taking the blood thinner Plavix along with aspirin helped prevent strokes and heart attacks in people with a common heartbeat abnormality that puts them at high risk of these problems, doctors reported Tuesday.
Medicine & Health / Medical research
Mar 31, 2009 |
4 / 5 (1) |
0
Clopidogrel
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix, by Sun Pharmaceuticals under the trade name Clopilet, by Ranbaxy Laboratories under the trade name Ceruvin. It works by irreversibly inhibiting a receptor called P2Y12. Adverse effects include hemorrhage.
For more information about Clopidogrel, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
